Mankind Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,007.80
20.55 (1.03%)
BSENSE

Mar 25

BSE+NSE Vol: 1.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,007.80",
    "chg": 20.55,
    "chgp": "1.03%",
    "dir": 1,
    "prev_price": "1,987.25",
    "mcapval": "82,887.67 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "1.15 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Mankind Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mankind-pharma-ltd-fallingrising-3908894",
        "imagepath": "",
        "date": "2026-03-24 01:36:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for several sessions, recording a consecutive three-day fall that has resulted in an 8.56% loss over this period. On the day in question, the share price hit a new 52-week low of ₹1,909.9, marking a 4.49% intraday decline. This underperformance is slightly worse than the Pharmaceuticals &amp; Drugs sector, which itself fell by 3.62%, indicating sector-wide weakness but with Mankind Pharma lagging marginally behind.</p>\n<p>Trading volumes have increased, with delivery volumes on 20 Mar rising by 83.22% compared to the five-day average, suggesting heightened investor activity. However, the weighted average price indicates that more shares were traded closer to the day’s low, signalling selling pressure. ..."
      },
      {
        "title": "Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-amid-market-downturn-3907445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3907445.png",
        "date": "2026-03-23 11:25:47",
        "description": "For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting sustained selling pressure amid broader sector weakness."
      },
      {
        "title": "Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-hits-52-week-low-amid-sector-and-market-downturn-3907446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3907446.png",
        "date": "2026-03-23 11:25:47",
        "description": "For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting intensified selling pressure amid broader sector weakness."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3905942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_mojoScore_3905942.png",
        "date": "2026-03-23 10:10:16",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Mankind Pharma Declines 6.45%: 4 Key Factors Behind the Weekly Slide",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-declines-645-4-key-factors-behind-the-weekly-slide-3905072",
        "imagepath": "",
        "date": "2026-03-21 11:02:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock opens at Rs.2,091.90, down 2.14%</p>\n                    <p><strong>19 Mar:</strong> New 52-week low of Rs.2,010.1 amid sharp decline</p>\n                    <p><strong>20 Mar:</strong> Further 52-week low at Rs.1,985.3 and technical downgrade</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.1,999.75, down 6.45% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,137.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,999.75</..."
      },
      {
        "title": "Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.1985.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-of-rs19853-3902565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3902565.png",
        "date": "2026-03-20 09:46:07",
        "description": "Mankind Pharma Ltd’s stock price declined to a fresh 52-week low of Rs.1985.3 today, marking a significant downturn amid ongoing challenges in performance and valuation pressures. The stock has underperformed its sector and benchmark indices, reflecting a cautious market stance towards the mid-cap pharmaceutical company."
      },
      {
        "title": "Mankind Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3902347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_technicaldot_3902347.png",
        "date": "2026-03-20 08:03:59",
        "description": "Mankind Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market environment for the pharmaceuticals sector."
      },
      {
        "title": "Mankind Pharma Ltd Hits Intraday Low Amid Price Pressure on 19 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-hits-intraday-low-amid-price-pressure-on-19-mar-2026-3900734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3900734.png",
        "date": "2026-03-19 15:16:09",
        "description": "Mankind Pharma Ltd experienced a notable decline on 19 Mar 2026, touching an intraday low of Rs 2010.1 as the stock faced significant price pressure amid a broadly bearish market environment and sectoral underperformance."
      },
      {
        "title": "Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2010.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-of-rs20101-3900722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3900722.png",
        "date": "2026-03-19 15:11:53",
        "description": "Mankind Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.2010.1 on 19 Mar 2026, marking a significant drop amid broader sector and market weakness. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the benchmark indices, reflecting ongoing concerns over valuation and recent financial performance."
      }
    ],
    "total": 492,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "18-Mar-2026",
      "details": "Please find attached press release titled Mankind Pharma acquires Rivotril brand for India reinforcing focus on chronic CNS therapies.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Mar-2026",
      "details": "Please find attached intimation regarding allotment of 23256 equity shares pursuant to Mankind Employee Stock Option Plan 2022.",
      "source": "BSE"
    },
    {
      "caption": "Clarification Submitted By Mankind Pharma Limited",
      "datetime": "27-Feb-2026",
      "details": "Please find attached clarification letter regarding increase in volume of security of the Mankind Pharma Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Mankind Pharma Ltd falling/rising?

2026-03-24 01:36:00

Recent Price Movement and Market Context

The stock has been under pressure for several sessions, recording a consecutive three-day fall that has resulted in an 8.56% loss over this period. On the day in question, the share price hit a new 52-week low of ₹1,909.9, marking a 4.49% intraday decline. This underperformance is slightly worse than the Pharmaceuticals & Drugs sector, which itself fell by 3.62%, indicating sector-wide weakness but with Mankind Pharma lagging marginally behind.

Trading volumes have increased, with delivery volumes on 20 Mar rising by 83.22% compared to the five-day average, suggesting heightened investor activity. However, the weighted average price indicates that more shares were traded closer to the day’s low, signalling selling pressure. ...

Read full news article

Mankind Pharma Declines 6.45%: 4 Key Factors Behind the Weekly Slide

2026-03-21 11:02:08

Key Events This Week

16 Mar: Stock opens at Rs.2,091.90, down 2.14%

19 Mar: New 52-week low of Rs.2,010.1 amid sharp decline

20 Mar: Further 52-week low at Rs.1,985.3 and technical downgrade

20 Mar: Week closes at Rs.1,999.75, down 6.45% for the week

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

18-Mar-2026 | Source : BSE

Please find attached press release titled Mankind Pharma acquires Rivotril brand for India reinforcing focus on chronic CNS therapies.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

16-Mar-2026 | Source : BSE

Please find attached intimation regarding allotment of 23256 equity shares pursuant to Mankind Employee Stock Option Plan 2022.

Clarification Submitted By Mankind Pharma Limited

27-Feb-2026 | Source : BSE

Please find attached clarification letter regarding increase in volume of security of the Mankind Pharma Limited

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mankind Pharma Ltd has declared 100% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available